Search

everythinglearnresearchcommunity

for

Search:↓

Androgens like testosterone increase colon muscle contractions by affecting calcium pathways.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by blocking male sex hormones.

The document concludes that scientists created various steroids with different properties, including a more effective semi-synthetic vitamin D.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Chemicals called 4-(alkylthio)- and 4-(arylthio)-benzonitrile derivatives can potentially reduce oil production on skin, which could help treat conditions like acne and hair loss.

Men with early-onset hair loss are less responsive to bromocriptine's heart and metabolism benefits.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Targeting androgen receptors with antiandrogen oligonucleotides could effectively treat hair loss.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

Finasteride boosts morphine's pain relief, stops tolerance, and reduces withdrawal in rats.

PEA boosts allopregnanolone production and reduces oxidative stress in brain cells.

SARM-induced changes in the androgen receptor are specific to each ligand and affect stability and protein interactions.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Nitrendipine and nifedipine effectively block muscle contractions, while papaverine relaxes them and minoxidil needs high amounts to work.

Allopregnanolone affects fear responses differently in male and female rats, possibly explaining sex differences in anxiety disorders.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Certain existing drugs, like glycopyrronium and botulinum toxin type A, may help treat excessive sweating.

Paroxetine relieves pain by increasing allopregnanolone levels.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Anabolic-androgenic steroids are dangerous and educating people about their risks is essential.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Astragaloside A may help fight lung cancer by targeting specific proteins.

Use antiandrogens and other treatments for hair loss.

Compound 3 protects the heart from damage by activating A1-adenosine receptors.

Agouti and AGRP affect pigmentation and obesity, with implications for metabolic disorders.

Progesterone reduces anxiety without needing progesterone receptors.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

Botulinum toxin may help hair loss by increasing blood flow and reducing harmful factors.

New treatments for male hypogonadism are easier to use and target specific tissues to reduce side effects.